Title:
BICYCLIC COMPOUNDS AS CDK INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2024/056019
Kind Code:
A1
Abstract:
Disclosed herein are bicyclic compound derivatives used as inhibitors of cyclin-dependent kinases. Disclosed herein is the use of these inhibitors for inhibiting cyclin-dependent kinases, and the use of such compounds for treating cancer.
More Like This:
| JPS61257964 | 3-ACYLAMINO-2-OXO-1-AZETIDINESULFONIC ACIDS |
| JP2008537748 | c-Met modulator and usage |
Inventors:
HUO CHANGXIN (CN)
ZHAO YU (CN)
ZHANG WEIXING (CN)
LIU HUAQING (CN)
WANG ZHIWEI (CN)
ZHAO YU (CN)
ZHANG WEIXING (CN)
LIU HUAQING (CN)
WANG ZHIWEI (CN)
Application Number:
PCT/CN2023/118754
Publication Date:
March 21, 2024
Filing Date:
September 14, 2023
Export Citation:
Assignee:
BEIGENE LTD (GB)
HUO CHANGXIN (CN)
HUO CHANGXIN (CN)
International Classes:
C07D417/12; A61K31/415; A61P35/00; C07D231/38; C07D401/12; C07D403/12
Domestic Patent References:
| WO2023168686A1 | 2023-09-14 | |||
| WO2023083201A1 | 2023-05-19 | |||
| WO2022174031A1 | 2022-08-18 | |||
| WO2020157652A2 | 2020-08-06 |
Attorney, Agent or Firm:
WU, FENG & ZHANG (CN)
Download PDF: